The author was given paper slippers and a windowless room at CAMH before beginning a rapid Klonopin taper.
BENZODIAZEPINE WITHDRAWAL DRIVES TORONTO PATIENT TO CRISIS
*In April 2021 a long‑term Klonopin user entered Toronto’s CAM H seeking help. Within weeks of a three‑week taper, he endured a cascade of physical and mental breakdowns. The account exposes how withdrawal can spiral into misdiagnoses and suicidal desperation.*
In April 2021 the author walked into Toronto’s Centre for Addiction and Mental Health (CAM H) after months of escalating instability and suicidal fantasies. A triage nurse escorted him to a windowless room, removed his belt and gave him paper slippers before a doctor suggested he stop Klonopin, a drug he had taken daily for nineteen years. The physician warned of possible withdrawal—blood‑pressure spikes, tremors, seizures—and instructed the patient to call 911 if they occurred. He left the facility with a taper plan promising drug‑free status in three weeks.
Within two days the patient felt his hands tingling and began sweating profusely. By the end of the first week he could no longer perform basic tasks. A cascade of symptoms—paresthesia, tinnitus, insomnia, hyperhidrosis, depersonalization, fasciculations, joint pain, vomiting, and a relentless “lightning” sensation—followed, each misread by clinicians as separate ailments. The physical torment spiraled into extreme anxiety, a concrete suicide plan, and a desperate search for validation beyond the hospital walls.
What symptoms did the patient experience during tapering?
Two days after a reduced Klonopin dose the patient reported tingling hands, profuse sweating, and a rapid heart rate. Within a week he could no longer exercise, write, bathe or cook. Paresthesia spread to arms, legs, feet and stomach, prompting a misdiagnosis of cervical radiculopathy. Tinnitus resurfaced at extreme volume. Insomnia replaced sleep, and hyperhidrosis forced him to pack spare shirts, resulting in a ten‑pound weight loss. Depersonalization altered his voice, while heightened sensory sensitivity made noise and light intolerable. Fasciculations appeared in his left biceps, and joint pain led doctors to label him with arthritis. Vomiting dominated his mornings, and a prolonged “lightning” sensation—distinct from SSRI brain zaps—became a hallmark of his withdrawal.
Why did clinicians struggle to address his condition?
The patient’s chart showed daily Klonopin use for nineteen years, yet the attending physician only offered a three‑week taper without a comprehensive plan. Early symptoms were dismissed as a pinched nerve, then arthritis, reflecting a pattern of misdiagnosis. General practitioners noted visible fasciculations but offered no solution. CAM H enrolled him in therapy after weeks of escalating anxiety, but the interventions did not target the acute physiological crisis. The patient’s suicidal ideation with a concrete plan emerged only after the physical torment intensified, highlighting a gap between mental‑health referrals and the urgent somatic needs of benzodiazepine withdrawal.
How did peer support influence his recovery outlook?
Months after discharge, the patient attended a Zoom‑based 12‑step meeting. He disclosed a recent pinched‑nerve diagnosis and his recent Klonopin taper. An anonymous participant warned against surgery, suggesting the symptoms stemmed from withdrawal. This peer intervention offered a glimmer of hope, counterbalancing the clinical neglect he had faced. The interaction underscored the role of community networks in recognizing withdrawal‑related complications when formal medical channels fall short.
What does this case reveal about benzodiazepine prescribing practices?
The narrative shows a patient writing his own prescriptions for nearly two decades, contradicting the doctor’s claim that long‑term use was inappropriate. The abrupt taper, despite known withdrawal risks, triggered severe physiological distress. Misdiagnoses of cervical radiculopathy and arthritis illustrate how withdrawal symptoms can masquerade as unrelated conditions. The case underscores the need for gradual, monitored deprescribing protocols and better clinician awareness of the breadth of benzodiazepine withdrawal phenomena.
Frequently asked questions
What withdrawal symptoms did the patient report after reducing Klonopin?
He experienced tingling, numbness, excessive sweating, rapid heart rate, insomnia, tinnitus, depersonalization, heightened sensory sensitivity, fasciculations, joint pain, vomiting, and a prolonged “lightning” sensation.
How long had the patient been using Klonopin before the taper?
He had been taking Klonopin daily for nineteen years, effectively writing his own prescriptions.
What misdiagnoses did doctors give during his withdrawal?
Clinicians first labeled his symptoms as cervical radiculopathy (pinched nerve) and later as arthritis.
The patient’s ordeal lays bare a systemic failure: long‑term benzodiazepine prescriptions, abrupt tapering, and a medical response that mistook withdrawal for unrelated pathologies. As more patients confront similar “other epidemics,” the pressure mounts on clinicians to adopt evidence‑based deprescribing and to recognize the full spectrum of withdrawal symptoms before lives are jeopardized.
Sources: [The Other Epidemic – Believer Magazine, archived at https://archive.ph/Tb1SZ]